INDP — Indaptus Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $7.38m
- $1.59m
Annual cashflow statement for Indaptus Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -14.1 | -7.71 | -14.3 | -15.4 | -15 |
| Depreciation | |||||
| Non-Cash Items | 1 | 1.49 | 2.82 | 2.53 | 2.31 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.413 | -5.07 | -1.58 | -0.518 | 0.392 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -11.5 | -11.3 | -13.1 | -13.4 | -12.3 |
| Capital Expenditures | -0.022 | -0.004 | 0 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.772 | 0.452 | -16.4 | 17.1 | 0 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.75 | 0.448 | -16.4 | 17.1 | 0 |
| Financing Cash Flow Items | 0.071 | 20.7 | 0 | — | -0.763 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 16 | 48.3 | 0 | — | 4.75 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.38 | 37.5 | -29.5 | 3.74 | -7.58 |